![](https://images.news18.com/ibnlive/uploads/2020/07/1595612658_news18_business_default_image.jpg)
Germany's CureVac NV said on Tuesday it has started a midstage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.
from Top Business News- News18.com https://ift.tt/36hX4sl
Comments
Post a Comment